Evidence map›Paper›PMID 34830874›Full record

ReviewCancers2021

The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer.

Albert Gibert-Ramos, David Sanfeliu-Redondo, Peio Aristu-Zabalza, Ana Martínez-Alcocer, Jordi Gracia-Sancho, Sergi Guixé-Muntet, Anabel Fernández-Iglesias

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. [SingleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Sinusoidal communication in chronic liver disease.Clinical and molecular hepatology · 2025
    Review
  12. Review
  13. Neoplastic Pseudocirrhosis Pathophysiological Deepening.Digestive diseases and sciences · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations.Cellular and molecular gastroenterology and hepatology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Albert Gibert-RamosLiver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.ORCID 0000-0002-5987-1164
David Sanfeliu-RedondoLiver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.ORCID 0000-0002-5617-0637
Peio Aristu-ZabalzaBarcelona Liver Bioservices, 08036 Barcelona, Spain.ORCID 0000-0003-2911-7870
Ana Martínez-AlcocerLiver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Jordi Gracia-SanchoLiver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.ORCID 0000-0001-7736-4089
Sergi Guixé-MuntetLiver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.ORCID 0000-0002-5748-1074
Anabel Fernández-IglesiasLiver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.ORCID 0000-0003-2364-6675
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversity of Bern · CH

Funding

AGAUR 2017-SGR-517Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas 19PI04Instituto de Salud Carlos III FIS PI17/00012 & PI20/00220
6 · The paper itself

Abstract

The liver sinusoids are a unique type of microvascular beds. The specialized phenotype of sinusoidal cells is essential for their communication, and for the function of all hepatic cell types, including hepatocytes. Liver sinusoidal endothelial cells (LSECs) conform the inner layer of the sinusoids, which is permeable due to the fenestrae across the cytoplasm; hepatic stellate cells (HSCs) surround LSECs, regulate the vascular tone, and synthetize the extracellular matrix, and Kupffer cells (KCs) are the liver-resident macrophages. Upon injury, the harmonic equilibrium in sinusoidal communication is disrupted, leading to phenotypic alterations that may affect the function of the whole liver if the damage persists. Understanding how the specialized sinusoidal cells work in coordination with each other in healthy livers and chronic liver disease is of the utmost importance for the discovery of new therapeutic targets and the design of novel pharmacological strategies. In this manuscript, we summarize the current knowledge on the role of sinusoidal cells and their communication both in health and chronic liver diseases, and their potential pharmacologic modulation. Finally, we discuss how alterations occurring during chronic injury may contribute to the development of hepatocellular carcinoma, which is usually developed in the background of chronic liver disease.

Indexed as

cirrhosisCLDhepatocellular carcinomaHSCKupffer cellLSECNASHportal hypertension

Identifiers

PMID34830874
PMCPMC8616349
OpenAlexW3211730362

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.